- Home
- WAVE vs LTRN Comparison
WAVE vs LTRN Comparison
Compare WAVE & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WAVE | LTRN |
|---|---|---|
| Founded | 2011 | 2013 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.4M | 31.5M |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | WAVE | LTRN |
|---|---|---|
| Price | $7.07 | $2.26 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $25.00 |
| AVG Volume (30 Days) | 9.0K | ★ 46.1K |
| Earning Date | 03-12-2026 | 03-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1,913.16 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.51 | $2.24 |
| 52 Week High | $9.85 | $5.74 |
Technical Indicators
Market Signals| Indicator | WAVE | LTRN |
|---|---|---|
| Relative Strength Index (RSI) | 63.46 | 30.09 |
| Support Level | $5.72 | N/A |
| Resistance Level | $7.11 | $3.65 |
| Average True Range (ATR) | 0.49 | 0.17 |
| MACD | 0.14 | -0.03 |
| Stochastic Oscillator | 73.12 | 4.79 |
Price Performance
Historical ComparisonAbout WAVE Eco Wave Power Global AB (publ)
Eco Wave Power Global AB is a Sweden-based wave energy company engaged in the development of a smart and cost-efficient WEC, technology that converts ocean and sea waves into clean electricity. Its WEC technology employs units of point absorber floating devices, referred to as floaters, which are installed on existing marine structures such as piers, breakwaters, and jetties, or in locations in which such marine structures are required. Geographical presence in Israel, USA and Mexico.
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.